Navigation Links
Laboratory Customers Name bioMerieux 'Top Of Class' for Microbiology
Date:12/17/2008

DURHAM, N.C., Dec. 17 /PRNewswire/ -- In a recent customer satisfaction survey of over 30,000 readers of ADVANCE for Administrators of the Laboratory, bioMerieux was voted by its customers as the "Top Of Class" winner for the microbiology category. The top-level lab managers and pathologists who subscribe to ADVANCE chose bioMerieux over other clinical laboratory suppliers because of the company's "great customer and technical support," "reliable instruments," and "quick response time."

Results of this survey were announced in the November issue of ADVANCE, with comments from readers on why they selected bioMerieux. The survey was conducted online at http://www.advanceweb.com between mid-June and mid-August, 2008. This year's survey had nearly 1,300 survey responses, primarily from top-level managers.

"The winners of our 'Top Of Class' survey are rated by readers of ADVANCE for Administrators of the Laboratory as the elite in their respective categories," said Lynn Nace, editor of ADVANCE for Administrators of the Laboratory. "And as such, they often raise the standard to improve the quality and accuracy of clinical laboratory testing and results reporting."

Microbiology was one of 13 categories polled by ADVANCE. For each category, readers were asked to fill in the name of the company they felt was top of the class and provide three reasons to support their nominations.

Published by Merion Publications Inc., ADVANCE for Administrators of the Laboratory is a medical laboratory and research specialty publication that boasts over 30,000 readers who manage labs or who support clinical labs. The monthly publication was founded in 1992 and provides original content for managers, directors, pathologists, and supervisors of clinical laboratories. For more information, visit http://www.advanceweb.com.

About bioMerieux

Advancing diagnostics to improve public health

A world leader in the field of in vitro diagnostics for over 45 years, bioMerieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2007, revenues reached euro 1.063 billion with 84% of sales outside of France.

bioMerieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Our products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

bioMerieux is listed on the NYSE Euronext Paris market (Symbol: BIM - ISIN: FR0010096479). Other information can be found at http://www.biomerieux.com.


'/>"/>
SOURCE bioMerieux
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
4. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
5. AviaraDx Announces CAP Accreditation of Its Laboratory Operations
6. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay
7. New White Paper Details Six Steps to Investigate and Prevent Laboratory Accidents
8. Codexis Opens Singapore Laboratory
9. Stem Cell Leader Beike Biotech and Chinas Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory
10. Ames Laboratory researchers solve fuel-cell membrane structure conundrum
11. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... ... PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing third-party MRI ... testing novel treatments in small animal subjects. Simultaneous PET/MRI imaging offers a solution ...
(Date:4/27/2016)... -- MedDay, a biotechnology company focused on the ... Catherine Moukheibir as Chairman of its Board of Directors. ... Garaud , who contributed to the rapid development of the ... Catherine started her career in strategy consulting and investment banking ... .  She held C-Suite level roles in some of ...
(Date:4/26/2016)... ... 26, 2016 , ... BaseHealth , the comprehensive predictive ... as Chief Business Officer. Arianpour, a genomics pioneer and visionary commercial leader with ... recently Chief Commercial Officer of Pathway Genomics. He has held senior executive roles ...
(Date:4/26/2016)... ... 26, 2016 , ... Mr. Palmer created the RPO business for Ceridian and ... multi-year managed services contract in the U.S. intelligence community with The SI (a Lockheed ... John Younger, founder of Accolo. “We are growing and his experience guiding our ...
Breaking Biology Technology:
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... (NSO), which operates the highest sample volume laboratory in ... Tute Genomics and UNIConnect, leaders in clinical sequencing informatics ... the launch of a project to establish the informatics ... NSO has been contracted by the ...
(Date:3/17/2016)... LONDON , March 17, 2016 ... market intelligence, forecasts the global biometrics market will ... an impressive 118% increase from 2015. Consumer electronics, ... with embedded fingerprint sensors anticipated to reach two ... Dimitrios Pavlakis , Research Analyst ...
Breaking Biology News(10 mins):